S
David Newman
Senior Product Director, Tykerb, GlaxoSmithKline
NOTED FOR: Launch of oncology treatment Tykerb
EXCEEDED RESULTS: Treated 5,500 patients
On what motivates him to succeed:
We think we have it tough. But that's nothing compared to fighting breast cancer. These women help us put our work in perspective, and give us a sense of mission to not necessarily sell Tykerb, but instead make sure every patient gets its benefit of efficacy.
David Newman
In a therapeutic area like oncology, you have a chance to make a real difference. That focus is what keeps me motivated day in and day out.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.